#151 Cardiorenal Considerations: 5 Pearls Segment

Cardiorenal syndrome involves complex, bidirectional dysfunction where acute heart failure leads to renal impairment, often driven more by venous congestion than low cardiac output. Diagnosis relies on identifying a "bland" urinalysis, as the presence of casts or protein suggests intrinsic renal injury rather than simple cardiorenal physiology. Management requires aggressive diuresis, where IV loop diuretics are titrated based on clinical response rather than rigid dosing, with spot urine sodium measurements serving as a reliable metric for diuretic efficacy. While creatinine often rises during effective decongestion, this fluctuation is frequently hemodynamically mediated rather than indicative of tubular injury, and clinicians should avoid prematurely stopping essential heart failure therapies like RAS inhibitors or SGLT2 inhibitors. When standard diuresis fails, adding boosters like metolazone, chlorothiazide, or acetazolamide can overcome resistance, provided electrolyte imbalances—particularly hypokalemia—are carefully managed.